Skip to main content
. 2024 Nov 23;32(4):525–534. doi: 10.5551/jat.65056

Table 2. Stroke characteristics and atherosclerosis scores of the enrolled patients.

Variables

Total

(N = 4,699 [100%])

CHIP carriers

(N = 180 [3.8%])

Non-CHIP carriers

(N = 4,519 [96.2%])

P Value
TOAST classification, n. (%) 0.33
LAA 1652 (35.2) 58 (32.2) 1594 (35.3)
CE 256 (5.4) 12 (6.7) 244 (5.4)
SAO 954 (20.3) 29 (16.1) 925 (20.5)
SOE 66 (1.4) 2 (1.1) 64 (1.4)
SUE 1771 (37.7) 79 (43.9) 1692 (37.4)
Admitting NIHSS, n 0.51
Mean±SD 4.5±4.3 4.7±4.3 4.5±4.3
Admitting NIHSS, n. (%) 0.90
≤ 3 2327 (49.5) 90 (50.0) 2237 (49.5)
>3 2372 (50.5) 90 (50.0) 2282 (50.5)
ICAS 0.99
0 2060 (43.8) 79 (43.9) 1981 (43.8)
>0 2639 (56.2) 101 (56.1) 2538 (56.2)
AS 0.96
Mean±SD 1.6±1.9 1.6±1.8 1.6±1.9

TOAST, Trial Org 10,172 in Acute Stroke Treatment; LAA, Large-artery atherosclerosis; CE, Cardiac embolism; SAO, Small-artery occlusion; SOE, stroke of other determined etiology; SUE, stroke of undetermined etiology; NIHSS, National Institutes of Health Stroke Scale. “ICAS = 0” indicating no stenosis, “ICAS >0” indicating 0-99% stenosis or occlusion. Atherosclerosis Scores (AS) were used to evaluate the atherosclerosis burden, which was determined by the number and degree of steno-occlusion of the intracranial arteries.